CRP and COVID-19: COVID-19 patients with hs-CRP > 31.10 (mg/l) had inferior outcomes with median OS times of 9 days (95% CI, 7 to 10) and 20 days (95% CI, 15 to NR) and OS rates of 25.0% and 50.0% in cohort 1 and 2, respectively.